Noninvasive Carotid Artery Imaging with a Focus on the Vulnerable Plaque

Neuroimaging Clinics of North America

Volumn 21, Issue 2, 2011, Pages 391-405

  Young, V E L ^a   Sadat, U ^a   Gillard, J H ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Carotid; Noninvasive imaging; Vulnerable plaque

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTERIAL WALL THICKNESS; B SCAN; BRAIN INFARCTION; CAROTID ARTERIOGRAPHY; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE CLASSIFICATION; DOPPLER ECHOGRAPHY; ECHOGRAPHY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFLAMMATION; MAGNETIC RESONANCE ANGIOGRAPHY; NEOVASCULARIZATION (PATHOLOGY); NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; STROKE; TRANSIENT ISCHEMIC ATTACK;

CAROTID STENOSIS; CEREBRAL ANGIOGRAPHY; HUMANS; IMAGE ENHANCEMENT;

EID: 79957795476     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2011.01.006     Document Type: Review

References (109)

1. Association AH Heart disease and stroke statistics - 2010 Update 2010, American Heart Association, Dallas (TX).
2. Wilterdink J.L., Easton J.D. Vascular event rates in patients with atherosclerotic cerebrovascular disease. Arch Neurol 1992, 49(8):857-863.
3. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991, 325(7):445-453.
4. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 1991, 337(8752):1235-1243.
5. Mayberg M.R., Wilson S.E., Yatsu F., et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA 1991, 266(23):3289-3294.
6. Rothwell P.M., Gutnikov S.A., Warlow C.P. Reanalysis of the final results of the European Carotid Surgery Trial. Stroke 2003, 34(2):514-523.
7. Ois A., Gomis M., Rodriguez-Campello A., et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke 2008, 39(6):1717-1721.
8. Halliday A., Mansfield A., Marro J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004, 363(9420):1491-1502.
9. Moore W.S., Young B., Baker W.H., et al. Surgical results: a justification of the surgeon selection process for the ACAS trial. The ACAS Investigators. J Vasc Surg 1996, 23(2):323-328.
10. Woo K., Garg J., Hye R.J., et al. Contemporary results of carotid endarterectomy for asymptomatic carotid stenosis. Stroke 2010, 41(5):975-979.
11. Muller J.E., Stone P.H., Turi Z.G., et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985, 313(21):1315-1322.
12. Dawkins A.A., Evans A.L., Wattam J., et al. Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology 2007, 49(9):753-759.
13. Heiserman J.E., Dean B.L., Hodak J.A., et al. Neurologic complications of cerebral angiography. AJNR Am J Neuroradiol 1994, 15(8):1401-1407. [discussion: 8-11].
14. Wardlaw J.M., Chappell F.M., Best J.J., et al. Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet 2006, 367(9521):1503-1512.
15. Barth A., Arnold M., Mattle H.P., et al. Contrast-enhanced 3-D MRA in decision making for carotid endarterectomy: a 6-year experience. Cerebrovasc Dis 2006, 21(5-6):393-400.
16. Mathiesen E.B., Joakimsen O., Bonaa K.H. Intersonographer reproducibility and intermethod variability of ultrasound measurements of carotid artery stenosis: the Tromso Study. Cerebrovasc Dis 2000, 10(3):207-213.
17. Lubezky N., Fajer S., Barmeir E., et al. Duplex scanning and CT angiography in the diagnosis of carotid artery occlusion: a prospective study. Eur J Vasc Endovasc Surg 1998, 16(2):133-136.
18. Blakeley D.D., Oddone E.Z., Hasselblad V., et al. Noninvasive carotid artery testing. A meta-analytic review. Ann Intern Med 1995, 122(5):360-367.
19. Saleem M.A., Sadat U., Walsh S.R., et al. Role of carotid duplex imaging in carotid screening programmes - an overview. Cardiovasc Ultrasound 2008, 6:34.
20. Saba L., Sanfilippo R., Montisci R., et al. Correlation between US-PSV and MDCTA in the quantification of carotid artery stenosis. Eur J Radiol 2010, 74(1):99-103.
21. Zhang Z., Berg M., Ikonen A., et al. Carotid stenosis degree in CT angiography: assessment based on luminal area versus luminal diameter measurements. Eur Radiol 2005, 15(11):2359-2365.
22. Thomas C., Korn A., Ketelsen D., et al. Automatic lumen segmentation in calcified plaques: dual-energy CT versus standard reconstructions in comparison with digital subtraction angiography. AJR Am J Roentgenol 2010, 194(6):1590-1595.
23. U-King-Im J.M., Fox A.J., Aviv R.I., et al. Characterization of carotid plaque hemorrhage: a CT angiography and MR intraplaque hemorrhage study. Stroke 2010, 41(8):1623-1629.
24. U-King-Im J.M., Trivedi R.A., Graves M.J., et al. Contrast-enhanced MR angiography for carotid disease: diagnostic and potential clinical impact. Neurology 2004, 62(8):1282-1290.
25. U-King-Im J.M., Hollingworth W., Trivedi R.A., et al. Contrast-enhanced MR angiography vs intra-arterial digital subtraction angiography for carotid imaging: activity-based cost analysis. Eur Radiol 2004, 14(4):730-735.
26. U-King-Im J.M., Trivedi R.A., Cross J.J., et al. Measuring carotid stenosis on contrast-enhanced magnetic resonance angiography: diagnostic performance and reproducibility of 3 different methods. Stroke 2004, 35(9):2083-2088.
27. Magarelli N., Scarabino T., Simeone A.L., et al. Carotid stenosis: a comparison between MR and spiral CT angiography. Neuroradiology 1998, 40(6):367-373.
28. Nederkoorn P.J., van der Graaf Y., Eikelboom B.C., et al. Time-of-flight MR angiography of carotid artery stenosis: does a flow void represent severe stenosis?. AJNR Am J Neuroradiol 2002, 23(10):1779-1784.
29. Yim Y.J., Choe Y.H., Ko Y., et al. High signal intensity halo around the carotid artery on maximum intensity projection images of time-of-flight MR angiography: a new sign for intraplaque hemorrhage. J Magn Reson Imaging 2008, 27(6):1341-1346.
30. Glagov S., Weisenberg E., Zarins C.K., et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987, 316(22):1371-1375.
31. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003, 108(14):1664-1672.
32. Saam T., Hatsukami T.S., Takaya N., et al. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 2007, 244(1):64-77.
33. Granada J.F., Kaluza G.L., Raizner A.E., et al. Vulnerable plaque paradigm: prediction of future clinical events based on a morphological definition. Catheter Cardiovasc Interv 2004, 62(3):364-374.
34. Li Z.Y., Howarth S., Tang T., et al. Does calcium deposition play a role in the stability of atheroma? Location may be the key. Cerebrovasc Dis 2007, 24(5):452-459.
35. Xu X., Ju H., Cai J., et al. High-resolution MR study of the relationship between superficial calcification and the stability of carotid atherosclerotic plaque. Int J Cardiovasc Imaging 2010, 26(Suppl 1):143-150.
36. Biasi G.M., Sampaolo A., Mingazzini P., et al. Computer analysis of ultrasonic plaque echolucency in identifying high risk carotid bifurcation lesions. Eur J Vasc Endovasc Surg 1999, 17(6):476-479.
37. Pedro L.M., Pedro M.M., Goncalves I., et al. Computer-assisted carotid plaque analysis: characteristics of plaques associated with cerebrovascular symptoms and cerebral infarction. Eur J Vasc Endovasc Surg 2000, 19(2):118-123.
38. Mathiesen E.B., Bonaa K.H., Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromso study. Circulation 2001, 103(17):2171-2175.
39. El-Barghouty N.M., Levine T., Ladva S., et al. Histological verification of computerised carotid plaque characterisation. Eur J Vasc Endovasc Surg 1996, 11(4):414-416.
40. Cave E.M., Pugh N.D., Wilson R.J., et al. Carotid artery duplex scanning: does plaque echogenicity correlate with patient symptoms?. Eur J Vasc Endovasc Surg 1995, 10(1):77-81.
41. Sabetai M.M., Tegos T.J., Clifford C., et al. Carotid plaque echogenicity and types of silent CT-brain infarcts. Is there an association in patients with asymptomatic carotid stenosis?. Int Angiol 2001, 20(1):51-57.
42. Biasi G.M., Froio A., Diethrich E.B., et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation 2004, 110(6):756-762.
43. Kalogeropoulos A., Terzis G., Chrysanthopoulou A., et al. Risk for transient ischemic attacks is mainly determined by intima-media thickness and carotid plaque echogenicity. Atherosclerosis 2007, 192(1):190-196.
44. Hallerstam S., Carlstrom C., Zetterling M., et al. Carotid atherosclerosis in relation to symptoms from the territory supplied by the carotid artery. Eur J Vasc Endovasc Surg 2000, 19(4):356-361.
45. Hirano M., Nakamura T., Kitta Y., et al. Assessment of carotid plaque echolucency in addition to plaque size increases the predictive value of carotid ultrasound for coronary events in patients with coronary artery disease and mild carotid atherosclerosis. Atherosclerosis 2010, 211(2):451-455.
46. von Sarnowski B., Ludemann J., Volzke H., et al. Common carotid intima-media thickness and Framingham Risk Score predict incident carotid atherosclerotic plaque formation: longitudinal results from the study of health in Pomerania. Stroke 2010, 41(10):2375-2377.
47. Trivedi R.A., U-King-Im J., Graves M.J., et al. Multi-sequence in vivo MRI can quantify fibrous cap and lipid core components in human carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg 2004, 28(2):207-213.
48. Yuan C., Kerwin W.S., Yarnykh V.L., et al. MRI of atherosclerosis in clinical trials. NMR Biomed 2006, 19(6):636-654.
49. Cai J.M., Hatsukami T.S., Ferguson M.S., et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 2002, 106(11):1368-1373.
50. Kwee R.M., van Oostenbrugge R.J., Prins M.H., et al. Symptomatic patients with mild and moderate carotid stenosis: plaque features at MRI and association with cardiovascular risk factors and statin use. Stroke 2010, 41(7):1389-1393.
51. Ota H., Yu W., Underhill H.R., et al. Hemorrhage and large lipid-rich necrotic cores are independently associated with thin or ruptured fibrous caps: an in vivo 3T MRI study. Arterioscler Thromb Vasc Biol 2009, 29(10):1696-1701.
52. Saam T., Underhill H.R., Chu B., et al. Prevalence of American Heart Association type VI carotid atherosclerotic lesions identified by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J Am Coll Cardiol 2008, 51(10):1014-1021.
53. Wang Q., Wang Y., Cai J., et al. Differences of signal evolution of intraplaque hemorrhage and associated stenosis between symptomatic and asymptomatic atherosclerotic carotid arteries: an in vivo high-resolution magnetic resonance imaging follow-up study. Int J Cardiovasc Imaging 2010, 26(Suppl 2):323-332.
54. Boussel L., Arora S., Rapp J., et al. Atherosclerotic plaque progression in carotid arteries: monitoring with high-spatial-resolution MR imaging-multicenter trial. Radiology 2009, 252(3):789-796.
55. U-King-Im J.M., Tang T.Y., Patterson A., et al. Characterisation of carotid atheroma in symptomatic and asymptomatic patients using high resolution MRI. J Neurol Neurosurg Psychiatry 2008, 79(8):905-912.
56. Sadat U., Weerakkody R.A., Bowden D.J., et al. Utility of high resolution MR imaging to assess carotid plaque morphology: a comparison of acute symptomatic, recently symptomatic and asymptomatic patients with carotid artery disease. Atherosclerosis 2009, 207(2):434-439.
57. Murphy R.E., Moody A.R., Morgan P.S., et al. Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation 2003, 107(24):3053-3058.
58. Clarke S.E., Hammond R.R., Mitchell J.R., et al. Quantitative assessment of carotid plaque composition using multicontrast MRI and registered histology. Magn Reson Med 2003, 50(6):1199-1208.
59. Young V.E., Patterson A.J., Sadat U., et al. Diffusion-weighted magnetic resonance imaging for the detection of lipid-rich necrotic core in carotid atheroma in vivo. Neuroradiology 2010, 52(10):929-936.
60. Yuan C., Kerwin W.S., Ferguson M.S., et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002, 15(1):62-67.
61. Gao T., Zhang Z., Yu W., et al. Atherosclerotic carotid vulnerable plaque and subsequent stroke: a high-resolution MRI study. Cerebrovasc Dis 2009, 27(4):345-352.
62. Zhao X., Underhill H.R., Yuan C., et al. Minimization of MR contrast weightings for the comprehensive evaluation of carotid atherosclerotic disease. Invest Radiol 2010, 45(1):36-41.
63. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105(9):1135-1143.
64. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874.
65. Coli S., Magnoni M., Sangiorgi G., et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008, 52(3):223-230.
66. Giannoni M.F., Vicenzini E., Citone M., et al. Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study. Eur J Vasc Endovasc Surg 2009, 37(6):722-727.
67. Xiong L., Deng Y.B., Zhu Y., et al. Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology 2009, 251(2):583-589.
68. Kerwin W., Hooker A., Spilker M., et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003, 107(6):851-856.
69. Aoki S., Aoki K., Ohsawa S., et al. Dynamic MR imaging of the carotid wall. J Magn Reson Imaging 1999, 9(3):420-427.
70. Kerwin W.S., O'Brien K.D., Ferguson M.S., et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 2006, 241(2):459-468.
71. Kerwin W.S., Oikawa M., Yuan C., et al. MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med 2008, 59(3):507-514.
72. Kerwin W.S., Zhao X., Yuan C., et al. Contrast-enhanced MRI of carotid atherosclerosis: dependence on contrast agent. J Magn Reson Imaging 2009, 30(1):35-40.
73. Owen D.R., Shalhoub J., Miller S., et al. Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast-enhanced US. Radiology 2010, 255(2):638-644.
74. Okane K., Ibaraki M., Toyoshima H., et al. 18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries. Eur J Nucl Med Mol Imaging 2006, 33(5):589-594.
75. Rudd J.H., Warburton E.A., Fryer T.D., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 105(23):2708-2711.
76. Rudd J.H., Myers K.S., Bansilal S., et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med 2008, 49(6):871-878.
77. Davies J.R., Rudd J.H., Fryer T.D., et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005, 36(12):2642-2647.
78. Silvera S.S., Aidi H.E., Rudd J.H., et al. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Atherosclerosis 2009, 207(1):139-143.
79. Corot C., Petry K.G., Trivedi R., et al. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 2004, 39(10):619-625.
80. Kawahara I., Nakamoto M., Kitagawa N., et al. Potential of magnetic resonance plaque imaging using superparamagnetic particles of iron oxide for the detection of carotid plaque. Neurol Med Chir (Tokyo) 2008, 48(4):157-161. [discussion: 161-2].
81. Trivedi R.A., Mallawarachi C., U-King-Im J.M., et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006, 26(7):1601-1606.
82. Trivedi R.A., U-King-Im J.M., Graves M.J., et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004, 35(7):1631-1635.
83. Tang T.Y., Patterson A.J., Miller S.R., et al. Temporal dependence of in vivo USPIO-enhanced MRI signal changes in human carotid atheromatous plaques. Neuroradiology 2009, 51(7):457-465.
84. Tang T.Y., Howarth S.P., Miller S.R., et al. Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis. Stroke 2008, 39(7):2144-2147.
85. Kooi M.E., Cappendijk V.C., Cleutjens K.B., et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107(19):2453-2458.
86. Howarth S.P., Tang T.Y., Trivedi R., et al. Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals. Eur J Radiol 2009, 70(3):555-560.
87. Tang T., Howarth S.P., Miller S.R., et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006, 37(9):2266-2270.
88. Font M.A., Fernandez A., Carvajal A., et al. Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. Front Biosci 2009, 14:3352-3360.
89. Tang T.Y., Howarth S.P., Miller S.R., et al. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultra small superparamagnetic iron oxide enhanced magnetic resonance study. J Neurol Neurosurg Psychiatry 2007, 78(12):1337-1343.
90. Tang T.Y., Howarth S.P., Miller S.R., et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009, 53(22):2039-2050.
91. Tang T.Y., Moustafa R.R., Howarth S.P., et al. Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis. Eur J Vasc Endovasc Surg 2008, 36(1):53-55.
92. Moustafa R.R., Izquierdo-Garcia D., Fryer T.D., et al. Carotid plaque inflammation is associated with cerebral microembolism in patients with recent TIA or stroke: a pilot study. Circ Cardiovasc Imaging 2010, 3(5):536-541.
93. Li Z.Y., Taviani V., Tang T., et al. The mechanical triggers of plaque rupture: shear stress vs pressure gradient. Br J Radiol 2009, 82(Spec No 1):S39-S45.
94. Sui B., Gao P., Lin Y., et al. Assessment of wall shear stress in the common carotid artery of healthy subjects using 3.0-tesla magnetic resonance. Acta Radiol 2008, 49(4):442-449.
95. Li Z.Y., Howarth S., Trivedi R.A., et al. Stress analysis of carotid plaque rupture based on in vivo high resolution MRI. J Biomech 2006, 39(14):2611-2622.
96. Li Z.Y., Howarth S.P., Tang T., et al. Structural analysis and magnetic resonance imaging predict plaque vulnerability: a study comparing symptomatic and asymptomatic individuals. J Vasc Surg 2007, 45(4):768-775.
97. Trivedi R.A., Li Z.Y., U-King-Im J., et al. Identifying vulnerable carotid plaques in vivo using high resolution magnetic resonance imaging-based finite element analysis. J Neurosurg 2007, 107(3):536-542.
98. Tang T.Y., Howarth S.P., Li Z.Y., et al. Correlation of carotid atheromatous plaque inflammation with biomechanical stress: utility of USPIO enhanced MR imaging and finite element analysis. Atherosclerosis 2008, 196(2):879-887.
99. Sadat U., Teng Z., Young V.E., et al. Impact of plaque haemorrhage and its age on structural stresses in atherosclerotic plaques of patients with carotid artery disease: an MR imaging-based finite element simulation study. Int J Cardiovasc Imaging 2010, 1-6. 10.1007/s10554-010-9679-z.
100. Young V.E.L., Tang T.Y., Sadat U., et al. Molecular MRI of atherosclerosis. Curr Cardiovasc Imaging Rep 2010, 3:4-11.
101. Radermacher K.A., Beghein N., Boutry S., et al. In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy. Invest Radiol 2009, 44(7):398-404.
102. Nahrendorf M., Jaffer F.A., Kelly K.A., et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114(14):1504-1511.
103. Cormode D.P., Chandrasekar R., Delshad A., et al. Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis. Bioconjug Chem 2009, 20(5):937-943.
104. Ronald J.A., Chen J.W., Chen Y., et al. Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation 2009, 120(7):592-599.
105. Smith B.R., Heverhagen J., Knopp M., et al. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI). Biomed Microdevices 2007, 9(5):719-727.
106. Cyrus T., Abendschein D.R., Caruthers S.D., et al. MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles. J Cardiovasc Magn Reson 2006, 8(3):535-541.
107. Spuentrup E., Botnar R.M., Wiethoff A.J., et al. MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol 2008, 18(9):1995-2005.
108. Amirbekian V., Aguinaldo J.G., Amirbekian S., et al. Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo. Radiology 2009, 251(2):429-438.
109. Muntendam P., McCall C., Sanz J., et al. The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease-study design and objectives. Am Heart J 2010, 160(1):49-57. e1.